A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, Lynne Lamb et al.|Journal of Clinical Oncology|2004Cited by 0